Nepra Foods Stock Price, News & Analysis

Nepra Foods (OTCQB:NPRFF) has received a management cease trade order (MCTO) from the British Columbia Securities Commission (BCSC) due to a delay in filing its annual financial statements. The company has been granted an extension until September 29, 2025 to file its Annual Financial Filings for the period ended March 31, 2025.

Under the MCTO, the CEO and CFO are restricted from trading company securities until the filings are completed and the order is revoked. This order does not affect regular shareholders' ability to trade their securities. The company is actively working to complete the required filings before the extended deadline.

Nepra Foods (OTCQB:NPRFF) has announced a delay in filing its annual financial statements for the year ended March 31, 2025. The company missed the required filing deadline of July 29, 2025, as its auditors need additional time to complete their audit.

As a result, Nepra has received a management cease trade order affecting the CEO and CFO's ability to trade company securities. The company expects to file the Annual Filings by August 29, 2025, with a final deadline set for September 29, 2025. In the interim, Nepra will provide bi-weekly default status reports in accordance with National Policy 12-203.

[]

Nepra Foods (OTCQB:NPRFF) has completed the first tranche of its non-brokered private placement, raising US$274,000 through the issuance of 4,566,667 units at US$0.06 per unit. Each unit comprises one common share and one warrant, with warrants exercisable at US$0.12 per share until June 27, 2027.

The company expects to close a second tranche around July 11th, 2025. The proceeds will be used for general working capital purposes. The securities are subject to a four-month hold period ending October 26, 2025.

Nepra Foods (NPRFF) has announced a non-brokered private placement offering to raise up to US$500,000 through the issuance of 8,333,333 units at US$0.06 per unit. Each unit comprises one common share and one share purchase warrant, with each warrant allowing the purchase of an additional share at US$0.12 for 24 months after issuance. The company plans to use the proceeds for general working capital purposes. The offering requires CSE approval and includes a four-month statutory hold period. The securities will be issued as restricted securities under U.S. Securities Act Rule 144(a)(3) and are not registered for U.S. distribution.

Nepra Foods issued a clarification regarding its revenue disclosure at CIRO's request, correcting financial information from its June 2 press release. The company reported significant growth, with Q4 2025 revenue reaching $1,661,224, marking a 211% increase from Q4 2024's $533,559. Full-year revenue for 2025 totaled $4,758,918, up 44% from 2024's $3,306,649. A major customer's revenue showed strong growth, with Q4 2025 revenue of $550,763, up 158% from Q4 2024's $213,639. This customer's full-year revenue increased 56% to $1,923,577 in 2025 from $1,230,604 in 2024. The company maintained stable gross profit margins, with company-wide margins at 20-25% and the major customer's margins at 33-34%.

Nepra Foods (NPRFF), a plant-based and allergen-free food innovator, reported exceptional growth in Q4 2025, with company-wide revenue surging 211% compared to Q4 2024. The company achieved a 56% revenue increase from a major undisclosed customer in May 2025, while full fiscal year 2025 revenue grew 44% year-over-year. Nepra's success stems from its proprietary ingredients, including plant-based proteins and egg replacement powders, which cater to major food manufacturers seeking allergen-free and vegan solutions. Founded in 2017 and headquartered in Centennial, Colorado, Nepra operates as a vertically integrated company, developing ingredients for commercial manufacturers while also producing its own consumer packaged goods. Chief Visionary Officer Chadwick White emphasized that their growth reflects successful scaling of operations following 12-18 months of R&D and product optimization efforts.

Nepra Foods (OTCQB:NPRFF), a company focused on allergen and gluten-free food ingredient technologies, has announced the resumption of trading on the OTCQB effective April 17, 2025, following approval from OTC Capital Markets. The company has also transitioned to Odyssey Trust Company as its corporate actions representative.

CEO Billy Hogan emphasized the company's commitment to providing shareholders with timely, factual, and complete information regarding its growth in the coming months. Management has expressed gratitude to both OTC Capital Markets and Odyssey for their assistance in facilitating these important transitions.

Nepra Foods (OTC PINK:NPRFF), a specialty food company focused on allergen-free and gluten-free ingredient technologies, has applied to upgrade its U.S. listing from the OTC Pink Market to the OTCQB Venture Market. This strategic move aims to enhance transparency, liquidity, and accessibility for investors.

The upgrade follows the recent appointment of Mark Retzloff as Chairman of the Board and represents the company's commitment to accelerating growth in the allergen-free food sector. The OTCQB, recognized by the SEC as a public market, requires stringent reporting and compliance standards.

According to CEO Billy Hogan, the upgrade is expected to provide enhanced liquidity for U.S. investors, improved transparency through higher disclosure standards, and broader access for non-Canadian investors. The company previously traded on OTCQB in 2022.

Nepra Foods (CSE:NPRA)(OTC PINK:NPRFF) has appointed industry veteran Mark Retzloff as Chairman of the Board of Directors. With over 51 years of experience in the natural, organic, and sustainable food sectors, Retzloff joins the specialty food company focused on allergen-free and gluten-free ingredient technologies.

CEO Billy Hogan emphasized that Retzloff's appointment comes at a important time as the company expands its product offerings. As Chairman, Retzloff will leverage his industry expertise and networks to advance Nepra's commitment to high-quality, regenerative foods in the allergen-free market, which is projected to reach USD $14 billion by 2032.

CVO Chadwick White highlighted that Retzloff's relationships will accelerate the company's development timeline and help fulfill its mission to improve the food system.